StreetAlpha.app
Home › Stocks › RDY

DR Reddys Laboratories Ltd (RDY)

Healthcare
$14.89
▲ +0.40%
LAST CLOSE · NOV 20

Dr. Reddy's makes generic medicines, active pharmaceutical ingredients and consumer healthcare products. It last closed at $14.89 on Nov 20, up 0.40% on the day.

AI Auto Pilots
Is RDY in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RDY.

Key Stats

Fiscal 2025
Results
Revenue
$3.8B
+13.8% vs a year ago
Net income
$663.0M
−0.7% vs a year ago
Free cash flow
$223.0M
5.9% margin
Gross margin
58.5%
$2.2B gross profit
Balance sheet
Cash & equivalents
$172.0M
At Mar 31
Shareholder equity
$3.9B
CEOG. V. Prasad
Fiscal year endsMarch
ExchangeNYSE
Financials history
FY2021: $2.6B$2.6BFY2021FY2022: $2.8B$2.8BFY2022FY2023: $3.0B$3.0BFY2023FY2024: $3.4B$3.4BFY2024FY2025: $3.8B$3.8BFY2025

From RDY's SEC filings, latest 20-F for the period ending Mar 31, 2025 (filed May 29). Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Ratings from the last 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on RDY
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on RDY

Technical Analysis

RDY · as of the Nov 20 close · updated each morning
Uptrend, nearing overbought

The stock is 2% above its 20 day and 10% above its 50 day average. It is 11% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 68), near overbought. The nearest support is the Pivot S1 at $14.80, and the nearest resistance the Pivot at $14.95.

Short trendBullish
Long trendBullish
MomentumImproving
StretchNear overbought
VolatilityNormal, 1.9%/day
Key levels
$15.6752 week high+5.2%
$15.08Swing high (Nov 9)+1.3%
$15.04Pivot R1+1.0%
$14.95Pivot+0.4%
$14.89Last close
$14.80Pivot S1−0.6%
$14.5520 day average−2.3%
$13.95Swing low (Jul 1)−6.3%
$13.3450 day average−10.4%
$13.31200 day average−10.6%
$12.86100 day average−13.6%
$11.3652 week low−23.7%
Indicators
RSI (14)68.12Strong, overbought above 70Neutral
MACD0.45Below its signal lineBearish
Stochastic80.6Near the top of its rangeOverbought
ADX (14)37.6Trending up
Williams %R-24.1Oversold below −80, overbought above −20Neutral
CCI (20)77.7Oversold below −100, overbought above 100Neutral
Rate of change−0.1%Change over 10 sessionsBearish
ATR (14)$0.28Typical daily range, 1.9% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for RDY

What happened before

See how RDY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow RDY usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How RDY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for RDYHow many large options trades hit RDY, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

RDY Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼87 buying vs 133 selling
  • ▲Shares held by funds +3.7%
  • ▼Funds holding -4
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding236240−1.7%
In funds' top 10110.0%
Held by funds–––
New / increased25 / 6228 / 76−16.3%
Reduced / sold out103 / 3097 / 37−0.7%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See RDY institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RDY is in one of them and how their past RDY trades turned out.

RDY in the AI portfolios
Loading…

RDY News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered RDY in an article yet. Here's the latest on the wider market.

RDY in the news

About DR Reddys Laboratories

Dr. Reddy's is a pharmaceutical company based in Hyderabad, India. It makes and sells generic medicines, both branded and unbranded, along with biosimilars and consumer healthcare products. It also manufactures active pharmaceutical ingredients, the core ingredients used in finished medicines, and offers contract research and manufacturing services to other drug companies. Its key markets include the United States, India, Russia, other former Soviet countries and Europe.

Headquarters
Hyderabad
Founded
1984